RSPO3 and neoplasm: SCRN1 accelerates tumor progression by the regulation of exocytosis of matrix metalloproteinase-2/9 (MMP-2/9) (55), while RSPO3 is an oncogenic driver that causes CRC and extensive crypt hyperplasia, concomitantly stimulating stem cells and supportive niche cells (56).